Smith & Nephew (SNN) Change in Receivables (2023 - 2024)
Smith & Nephew (SNN) posted quarterly Change in Receivables of -$44.0 million for Q4 2024, down 1566.67% year-on-year from $3.0 million in Q1 2024, and down 1566.67% on a QoQ basis from $3.0 million in Q4 2023.
Smith & Nephew (SNN) Change in Receivables (2023 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Receivables for 2 consecutive years, with -$44.0 million the latest figure, recorded in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -44.00 Mn |
| Dec 31, 2024 | -44.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |